AFV

(redirected from Amniotic Fluid Volume)
AcronymDefinition
AFVAlternative-Fuel Vehicle
AFVAmerica's Funniest Home Videos (TV show)
AFVAlternative Fuel Vehicle
AFVArmored Fighting Vehicle
AFVAmerica's Funniest Videos
AFVAmerica's Funniest Home Video
AFVAmniotic Fluid Volume
AFVAssociation Française du Violoncelle (French: French Cello Association)
AFVAssociation Football Virois (French football club; Vire, France)
AFVA Fairer Victoria (Australia)
AFVArmored Family of Vehicles
AFVAvantage Fiscal (special category of Belgium shares)
AFVAssociation Française du Vitiligo
AFVAlpine Forez Velay (French car club)
AFVAbdominal Visceral Fat
AFVAntiflood Valve (NASA)
AFVAngel Flight for Veterans
AFVAccompanied Field Visit
AFVAwaiting Fix Verification
References in periodicals archive ?
Thus, it is not entirely clear whether the adverse perinatal outcomes reflect the sequel of these conditions or reduced amniotic fluid volume itself contributes to adverse outcomes.
According to Quintero and his group, increased amniotic fluid volume in the recipient accompanied by oligohydramnios in the donor, is associated with an increased risk for adverse outcomes.
The role of ultrasound assessment of amniotic fluid volume in the management of the postdate pregnancy.
The impact of amniotic fluid volume assessed intrapartum on perinatal outcome.
Regulation of amniotic fluid volume by intramembranous absorption in sheep: role of passive permeability and vascular endothelial growth factor.
Amniotic fluid volume assessment with the four-quadrant technique at 36-42 weeks' gestation.
1,2) Because adverse outcomes occur in high-risk pregnancies complicated by low amniotic fluid volume, oligohydramnios commonly prompts labor induction?
96 g/kg body weight), injected on the 10th day of pregnancy (PD10), significantly reduced maternal weight gain, fetal weight, amniotic fluid volume and umbilical cord length.
Amniocentesis also is intended to normalize the amniotic fluid volume between the recipient and donor twins' sacs.
In contrast, in bilateral uropathies with normal amniotic fluid volume or moderate oligohydramnios and without major structural anomaly of the renal parenchyma, neonatal survival is expected, but postnatal morbidity is difficult to predict by sonography alone (1-3).
One method is to obtain a biophysical profile per ultrasound exam, which will offer information about the maturity of the placenta as well as amniotic fluid volume and bone maturity of the fetus.